US equities
|
MU
$795.41
▲+0.02%
SNDK
$1,037.40
▲+0.00%
NVDA
$200.13
▲+0.00%
AMD
$488.78
▲+0.00%
SKHY
$143.07
▲+0.00%
INTC
$58.27
▲+0.00%
TSLA
$385.19
▲+0.00%
SPCX
$135.92
▲+0.00%
MU
$795.41
▲+0.02%
SNDK
$1,037.40
▲+0.00%
NVDA
$200.13
▲+0.00%
AMD
$488.78
▲+0.00%
SKHY
$143.07
▲+0.00%
INTC
$58.27
▲+0.00%
TSLA
$385.19
▲+0.00%
SPCX
$135.92
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Character Biosciences
Character Biosciences to Present at Upcoming Investor Conferences
November 03, 2026
From
Character Biosciences
Via
Business Wire
Fierce Biotech Names Character Biosciences a “Fierce 15” Biotech Company of 2025
September 22, 2025
From
Character Biosciences
Via
Business Wire
Character Biosciences Expands Leadership Team with Key Appointments and Announces Series B Extension
September 17, 2025
From
Character Biosciences
Via
Business Wire
Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases
March 25, 2025
From
Character Biosciences
Via
Business Wire
Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine
January 10, 2025
From
Character Biosciences
Via
Business Wire
Character Biosciences Strengthens Leadership Team with Appointment of Laura Carter, Ph.D. as Chief Scientific Officer
September 13, 2023
From
Character Biosciences
Via
Business Wire